Search
for
Sort by
Research 481–510 of 1000+
- Interventional studies for polycystic ovarian syndrome in children and adolescents
- Association between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
- Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review
- DMBA/TPA Treatment Is Necessary for BCC Formation from Patched Deficient Epidermal Cells in Ptch flox/flox CD4Cre +/− Mice
- The Evaluation and Management of Hirsutism
- Polycystic Ovary Syndrome: Features, Diagnostic Criteria and Treatments
- Polycystic Ovary Syndrome
- Testosterone Therapy in Premenopausal Women
- The effect of minocycline on the metabolism of androgens by human oral periosteal fibroblasts and its inhibition by finasteride
- Hirsutism
- Polymorphism of CAG and GGN repeats of androgen receptor gene in women with polycystic ovary syndrome
- Polycystic ovary syndrome
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- The role of androgen therapy
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Polycystic ovary syndrome: a dermatologic approach
- Light emitting diodes technology-based photobiomodulation therapy (PBMT) for dermatology and aesthetics: Recent applications, challenges, and perspectives
- Testosterone Treatment in Women – An Overview
- Treatment of hyperandrogenism in women
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- Clinical manifestations of polycystic ovary syndrome
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- The Effect of Simvastatin on Plasma Steroid Hormone Levels in Metformin-Treated Women with Non-Classic Congenital Adrenal Hyperplasia
- Androgen receptor CAG repeat length is associated with ovarian reserve but not with ovarian response
- Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats
- Prenatal Androgenization of Ewes as a Model of Hirsutism in Polycystic Ovary Syndrome
- Skin Diseases in Horses
- Skin Disorders in Overweight and Obese Patients and Their Relationship With Insulin
- The role of androgens in hormone replacement therapy
- Association of Polycystic Ovarian Syndrome (PCOS) With Vaginal Microbiome Dysbiosis: A Scoping Review